Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer

An estimated 2.2 million people worldwide are diagnosed with lung cancer each year

- PMLiVE

UKRI announces investment of over £100m to sustain UK infrastructure

The investment will be used to maintain the production of world-class research infrastructure

- PMLiVE

MS charities urge UK government to improve patient mental health support

Around 130,000 people in the UK have MS with half dealing with depression at some stage

Novel Oncology Therapies Require Innovative Methods in Oncology Modeling

Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.

OPEN Health

- PMLiVE

FDA advisory committee backs Sarepta’s Duchenne muscular dystrophy gene therapy

The disease occurs in up to one in every 5,000 newborn males worldwide

- PMLiVE

Astellas Pharma’s non-hormonal menopause drug granted FDA approval

Vasomotor symptoms affect up to 80% of menopausal individuals in the US

- PMLiVE

Research finds a third with dementia concerns face long wait for medical help

It is estimated that by 2040 1.6m people will suffer from dementia in the UK

- PMLiVE

WHO report shows progress as well as gaps in AMR antibiotic pipeline

AMR has been declared as one of the top ten global public health threats by the organisation

Patient Support Program (PSP) Optimization: A Customer Story

Our client was looking to gather detailed feedback on their Patient Support Program (PSP) in order to improve its useability, offerings, and value to patients and caregivers. Working closely with...

Impetus Digital

- PMLiVE

Spotting the Signs of Dementia is the First Step to Diagnosis

As part of our contribution to dementia awareness week, we wanted to help ground people in the terms often used interchangeably to describe dementia.

Mednet

- PMLiVE

Bristol Myers Squibb’s Sotyktu approved by MHRA for plaque psoriasis

Up to 1.8 million people in the UK are affected by some form of the inflammatory condition

- PMLiVE

GSK’s five-in-one meningococcal vaccine candidate shows promise in phase 3 trial

There are no approved vaccines offering simultaneous protection against all five serogroups

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links